Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-03-11 @ 7:00 AM
Study NCT ID:
NCT02711202
Status:
COMPLETED
Last Update Posted:
2025-06-04
First Post:
2016-03-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Sponsor:
Institute for Clinical and Experimental Medicine
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
EudraCT Number: 2006-003110-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None